XTX Topco’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$343K Sell
1,170
-2,509
-68% -$825K 0.01% 2366
2025
Q4
$1.29M Sell
3,679
-235
-6% -$79.4K 0.03% 851
2025
Q3
$1.26M Buy
+3,914
New +$1.22M 0.07% 434
2024
Q2
Sell
-1,131
Closed -$586K 2019
2024
Q1
$586K Buy
1,131
+653
+137% +$325K 0.08% 395
2023
Q4
$225K Sell
478
-6,861
-93% -$3.17M 0.05% 861
2023
Q3
$3.2M Buy
7,339
+3,073
+72% +$1.39M 0.55% 2
2023
Q2
$1.9M Buy
+4,266
New +$1.97M 0.34% 11
2023
Q1
Sell
-1,576
Closed -$808K 1382
2022
Q4
$808K Buy
+1,576
New +$800K 0.17% 132
2021
Q4
Sell
-2,198
Closed -$819K 767
2021
Q3
$819K Buy
+2,198
New +$835K 0.28% 77
2021
Q2
Sell
-1,561
Closed -$560K 880
2021
Q1
$560K Buy
+1,561
New +$502K 0.27% 66

Other funds holding ELV

XTX Topco's ELV Position: Q1 2026 in Review

XTX Topco reduced its Elevance Health (ELV) stake by 68% in Q1 2026, selling an estimated $825K and leaving 1,170 shares worth $343K. The position accounts for 0.01% of the portfolio, ranked #2366.

XTX Topco first reported a position in ELV in Q1 2021 and has held it in 10 quarters since. The position peaked at $3.2M in Q3 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • XTX Topco held 1,170 shares of Elevance Health worth $343K as of Q1 2026.
  • XTX Topco sold 2,509 Elevance Health shares in Q1 2026, an estimated $825K.
  • Elevance Health made up 0.01% of XTX Topco's portfolio in Q1 2026, its #2366 holding.
  • XTX Topco first reported a position in Elevance Health in Q1 2021 and has held it in 10 quarters since.
  • XTX Topco's Elevance Health position peaked at $3.2M in Q3 2023.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.